Patients

Etre soigné dans un Centre de lutte contre le cancer

Découvrez notre démarche

Professionnels de santé

La recherche et la prise en charge UNICANCER

Accédez à votre espace

Vous cherchez un Centre

Les 20 centres de lutte contre le cancer sur l'ensemble du territoire

Voir tous les Centres
Accueil » La recherche UNICANCER » R&D UNICANCER » Les publications de R&D UNICANCER » Les publications

Publications R&D UNICANCER

09/11/2010

Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide ...

Breast Cancer Research and Treatment, 9 novembre 2010

27/07/2010

DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and ...

Proceedings of the National Academy of Sciences, USA, 27 juillet 2010

21/07/2010

Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients: results of the PACS 01 economic study

Annals of Oncology Advance Access, 21 juillet 2010, n° 7, 1448-1454

10/07/2010

Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial

Journal of Clinical Oncology, 10 juillet 2010, vol 28, n° 20, 3284-3291

09/07/2010

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group ...

Annals of Oncology Advance Access, 9 juillet 2010

29/06/2010

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer

Breast Cancer Research and Treatment, 29 juin 2010

20/04/2010

Impact of EWS-ETS fusion Type on Disease Progression in Ewing’s Sarcoma/Peripheral Primitive Neuroectodermal Tumor: ...

Journal of Clinical Oncology, 20 avril 2010, vol 28, n° 12, 1982-1988

01/04/2010

Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase ...

Journal of Clinical Oncology, vol 28, n° 10, avril 2010, 1638-1644

02/03/2010

Participants’ uptake of clinical trial results: a randomised experiment

British Journal of Cancer (2010) 102, 1081–1084

02/02/2010

Proposal for size justification of expanded cohort at phase-2-recommended dose

Invest New Drugs, 2 février 2010